0.0065USD-7.14%Mkt Cap: 861445 USDP/E: —Last update: 2026-06-01
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a ho…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap861.45K USD
Enterprise Value56.68M USD
Revenue (TTM)20.24M USD
Gross Profit15.57M USD
Net Income (TTM)391.00K USD
Revenue/Share0.1590 USD
Last Price0.0065 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30048L2034
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-18.35
EV/Revenue2.80
P/S0.05
P/B-0.01
EPS (TTM)-0.05
EPS (Forward)-0.55
52W Range
0.001029% of range0.0200
52W High0.0200 USD
52W Low0.0010 USD
Profitability
Gross Margin77.12%
Oper. Margin-508.23%
EBITDA Margin-15.26%
Profit Margin1.94%
ROE-0.53%
ROA1.93%
Growth
Revenue Growth6.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.99M USD
CapEx (TTM)5.00K USD
FCF Margin-5.13%
FCF Yield-120.51%
Net Debt50.84M USD
Net Debt/EBITDA-16.46
Balance Sheet
Debt/Equity-0.73
Current Ratio0.08
Quick Ratio0.03
Book Value/Sh-0.5860 USD
Cash/Share0.0120 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2018
Splits
Last Split1:125
Split DateMay 18, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.132.53M
Float132.53M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float11.01%
Short % Out.10.98%
Shares Short69.46K
Short (prev mo.)142.57K
Technical
SMA 500.0080 (-18.5%)
SMA 2000.0097 (-32.9%)
Beta-1.31
S&P 52W Chg27.94%
Avg Vol (30d)290.94K
Avg Vol (10d)145.87K
Technical Indicators
RSI (14)47.8
MACD-0.0003
MACD Signal-0.0004
MACD Hist.+0.0001
BB Upper0.0078 USD
BB Middle0.0068 USD
BB Lower0.0057 USD
BB Width31.01%
ATR (14)0.0012 USD
Vol Ratio (20d)0.05x